Genxone SA NEWCONNECT:GX1:
OFFER FOR MICROBIOME SEQUENCING SERVICES CHOSEN AS MOST FAVORABLE IN TENDER BY NATIONAL INSTITUTE OF GERIATRICS, RHEUMATOLOGY AND REHABILITATION
GROSS VALUE OF THE OFFER IS 246,728.16 ZLOTYS
Genxone Offer For Microbiome Sequencing Services Chosen As Most Favorable In Tender
Earlier from Genxone Sa
- genXone Q4 Net Loss At 0.2 Million Zlotys
- Genxone Q3 Net Loss At 0.6 Mln Zlotys
- Gexone 194.1 Mln Zlotys Offer Chosen As Most Favourable In Tender